Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA291902
Max Phase: Preclinical
Molecular Formula: C6H9NO4
Molecular Weight: 159.14
Molecule Type: Small molecule
Associated Items:
ID: ALA291902
Max Phase: Preclinical
Molecular Formula: C6H9NO4
Molecular Weight: 159.14
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)[C@H]1NCC[C@H]1C(=O)O
Standard InChI: InChI=1S/C6H9NO4/c8-5(9)3-1-2-7-4(3)6(10)11/h3-4,7H,1-2H2,(H,8,9)(H,10,11)/t3-,4+/m1/s1
Standard InChI Key: GLQKHRAKKLRGNR-DMTCNVIQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 159.14 | Molecular Weight (Monoisotopic): 159.0532 | AlogP: -0.87 | #Rotatable Bonds: 2 |
Polar Surface Area: 86.63 | Molecular Species: ZWITTERION | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 1.82 | CX Basic pKa: 11.24 | CX LogP: -3.22 | CX LogD: -5.73 |
Aromatic Rings: 0 | Heavy Atoms: 11 | QED Weighted: 0.49 | Np Likeness Score: 0.94 |
1. Bridges RJ, Lovering FE, Humphrey JM, Stanley MS, Blakely TN, Cristofaro MF, Chamberlin A. (1993) Conformationally restricted inhibitors of the high affinity -glutamate transporter, 3 (1): [10.1016/S0960-894X(00)80103-1] |
2. Bridges RJ, Lovering FE, Humphrey JM, Stanley MS, Blakely TN, Cristofaro MF, Chamberlin A. (1993) Conformationally restricted inhibitors of the high affinity -glutamate transporter, 3 (1): [10.1016/S0960-894X(00)80103-1] |
3. Hashimoto K, Yamamoto O, Horikawa M, Ohfune Y, Shirahama H. (1994) Synthesis and neurobiological actions of pyrrolidine-2,3-dicarboxylic acids (PRDA). Conformationally restricted analogues of L-aspartate, 4 (15): [10.1016/S0960-894X(01)80383-8] |
4. Parr IB, Boehlein SK, Dribben AB, Schuster SM, Richards NG.. (1996) Mapping the aspartic acid binding site of Escherichia coli asparagine synthetase B using substrate analogs., 39 (12): [PMID:8691431] [10.1021/jm9601009] |
Source(1):